A Comprison of Cost-effectiveness Between Interferon ?-2b and Lamivudine in Treating Chronic Hepatitis B

Ruolun WANG; Xiaoguang YE

A Comprison of Cost-effectiveness Between Interferon ?-2b and Lamivudine in Treating Chronic Hepatitis B / 中国药房

Ruolun WANG; Xiaoguang YE.

China Pharmacy ; (12)2001.

Article in Chinese | WPRIM | ID: wpr-519321

ABSTRACT

ABSTRACT

0 05),the cost-effectiveness ratios were 762 49 and 111 85 respectively(P

Interferon ?-2b; Lamivudine; chronic hepatitis B; cost-effectiveness analysis

Fulltext

XML

Search on Google

Full text: Available Index: WPRIM (Western Pacific) Type of study: Health economic evaluation Language: Chinese Journal: China Pharmacy Year: 2001 Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

Search on Google

Full text: Available Index: WPRIM (Western Pacific) Type of study: Health economic evaluation Language: Chinese Journal: China Pharmacy Year: 2001 Type: Article